Company Overview and News

0
IJM Plantations a target, cash-rich IOI leading suitor

2018-08-06 thestar.com.my
High demand: Among the suitors eyeing IJM Plantations, which has 61,000ha of planted area in Sabah, Kalimantan and Sumatra, are plantation groups such as IOI and Hap Seng Plantations.
5138 1996 2216 5254

0
Getting a grip on Hap Seng Plantations’ aborted Kretam deal

2018-06-25 thestar.com.my
In the hey days of the market in the 1990s, public viewing galleries will cheer every time when they see Kretam Holdings Bhd ’s (Kretam) share price move along with other market darlings of the yesteryear. They would say in the Malay language, “Ketam mari, Ketam mari”, as in the stock is having an upward run and it’s time to “jump in.”
5138 1996

15
KLCI down 0.66% as investor sentiment remains jittery

2018-06-22 theedgemarkets
KUALA LUMPUR (June 22): The FBM KLCI fell 0.66% at mid-morning today, tracking losses at the regional markets as investor sentiment remained jittery given the spectre of a global trade war.
APEXF 7090 UPBMF 4065 7235 BATS 4162 2089 9334 KLKBY 2445 4863 5347 1996 0026 TNABY MYTEF 2836 TNABF MGFCF

0
Kretam stake buy cancellation a positive for Hap Seng Plantations

2018-06-20 theedgemarkets
Hap Seng Plantations Holdings Bhd (June 19, RM2.21) Upgrade to market perform with a higher target price (TP) of RM2.15: Hap Seng Plantations Holdings Bhd announced that it had terminated its share sale agreement to acquire 55% of Kretam Holdings Bhd from Datuk Lim Nyuk Sang @ Freddie Lim and Santaprise Sdn Bhd after finalising its due diligence process and finding the results “unsatisfactory and unacceptable”.
5138 1996

14
KLCI extends loss, drops 0.65% as banks drag

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): The FBM KLCI extended its loss at the midday break today and dropped 0.65%, dragged by banking heavyweights Public Bank Bhd and Malayan Banking Bhd (Maybank).
HLFBF APEXF PBLOF 7090 MLYNF 7113 4065 TPGVF 1295 2852 3026 3301 2836 MLYBY 1082 5681 0096 5202 7123 TGLVY 1155 4588 1996 0026 3719

4
Kretam rebounds after hitting limit down

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): Kretam Holdings Bhd’s shares rebounded and was among the top five most actively traded stocks on Bursa Malaysia today after hitting limit down yesterday.
5138 1996 BSMAF 1818

8
KLCI down 0.42% in line with the regional pullback

2018-06-19 theedgemarkets
KUALA LUMPUR (June 19): The FBM KLCI was down 0.42% at mid-morning today, in line with the pullback at most regional markets as the tariff tit-for-tat between the US and China intensified.
HLFBF APEXF 7090 5150 4065 1082 5681 BATS 4162 5014 7123 3026 3867 1996 0026 MYPRY 3719

0
Kretam rebounds from share sell down, rises 4.3%

2018-06-19 thestar.com.my
KUALA LUMPUR: Kretam Holdings Bhd , which saw its share price almost halve after Hap Seng Plantations Holdings Bhd dropped its RM1.18bil takeover bid, has rebounded in early trade Tuesday.
5138 1996

0
Kretam tanks as RM1.18b deal scrapped

2018-06-19 theedgemarkets
KUALA LUMPUR: Kretam Holdings Bhd’s share price yesterday sank to its lowest since September 2015 with some half a billion ringgit worth of market capitalisation wiped out in a day, after Hap Seng Plantations Holdings Bhd called off a plan to take up a controlling 55% stake in the company.
5138 1996

9
FBM KLCI down 18.35 points; ringgit weakens past 4.00 against US dollar

2018-06-18 theedgemarkets
KUALA LUMPUR (June 18): The FBM KLCI fell 18.35 points or 1.04%, tracking Asian share losses as investors evaluated the impact of the US-China trade spat on world markets.
KLKBY 2445 1996 5681 BSMAF 1818

23
KLCI pares loss, down 0.78% as sentiment stays tepid

2018-06-18 theedgemarkets
KUALA LUMPUR (June 18): The FBM KLCI pared some of its losses at the midday break and was down 0.78%, with tepid sentiment tracking losses at the regional markets.
APEXF 7251 7090 7113 BATS TPGVF 4162 3034 KLKBY 5226 5347 3301 TNABY AXXTF HRGHY 5681 2291 1163 5168 TGLVY 2445 1996 6888 5819 TNABF

0
Stock With Momentum: Hap Seng Consolidated

2018-06-18 theedgemarkets
Hap Seng Consolidated Bhd (+ve) TRADING of the shares in Hap Seng Consolidated Bhd (fundamental: 1.3/3, valuation: 1.3/3) triggered our momentum algorithm last Thursday for the first time this year. The group saw 937,700 shares traded.
5138 1996 3034

4
Kretam slumps to near three-year low; short selling suspended

2018-06-18 theedgemarkets
KUALA LUMPUR (June 18): Kretam Holdings Bhd's stock price nosedived in early trade today to its lowest since September 2015, after its plans to sell a 55% stake to Hap Seng Plantations Holdings Bhd had been called off.
5138 1996 BSMAF 1818

1
The Week Ahead: Focus on oil price and full Cabinet line-up

2018-06-18 theedgemarkets
The possible announcement of the full Cabinet line-up could be among the highlights this week, even as businesses continue to cash in on the World Cup 2018 fever and the zero-rated Goods and Services Tax (GST) “tax holiday”. There was no Cabinet meeting last Wednesday (June 13) with Prime Minister Tun Dr Mahathir Mohamad just returning from a work trip in Japan (June 11 and 12) and Hari Raya Puasa festivities on June 15 and 16.
8591 5139 9571 5797 1996 0900 5263 5098 0065 5156

27
KLCI down 1.07% as key blue chips drag

2018-06-18 theedgemarkets
KUALA LUMPUR (June 18): The FBM KLCI fell 1.07% at mid-morning today as regional markets spooked by the escalating US-China trade spat mostly retreated.
PBLOF 7251 5183 PECGF 7060 UPBMF 4065 5681 2291 1163 1295 2089 5014 KLKBY 2445 5347 3301 1996 TNABY 5819 MYPRY TNABF GEBHF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...